查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403393

結構生物學和分子建模技術市場預測至 2030 年：按產品、工具、技術、應用和地區進行的全球分析

Structural Biology & Molecular Modeling Market Forecasts to 2030 - Global Analysis By Product, Tools (Software as a Service & Standalone Modeling, Visualization & Analysis, Databases and Other Tools), Technology, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2023年全球結構生物學和分子建模技術市場規模將達到49.1億美元，預測期內複合年成長率為18.2%，預計到2030年將達到158.5億美元。

結構生物學和分子建模技術是兩個密切相關的領域，在分子層面上理解生物大分子的結構和功能方面發揮著重要作用。結構生物學和分子建模技術是多功能工具，可用於廣泛的應用，從基礎研究到醫學、農業和工業的實際應用。在分子層面上理解生物過程有助於許多科學和技術領域的進步。

根據 2021 年 9 月發表在 MDPI日誌上的一篇研究論文，周邊動脈疾病(PAD) 的盛行率估計在 3% 至 12% 之間，影響美國和歐洲約 2700 萬人。

促生長因子：慢性病增加

慢性疾病通常涉及複雜的分子途徑。結構生物學透過提供詳細資訊來幫助識別和檢驗潛在的藥物研發標靶。結構生物學和分子建模技術有助於潛在藥物研發標靶的識別和特異性治療藥物的設計。癌症和神經退化性疾病等慢性病的增加加速了對標靶治療和個體化治療的需求。

成長抑制因素：對生物系統的了解有限

儘管取得了進步，我們對複雜生物系統的理解仍在不斷發展中。對目標蛋白3D結構的有限了解阻礙了有效候選藥物的識別和設計。結果，藥物開發可能變得更慢、效率更低。此外，蛋白質-配體相互作用的預測準確性差和生物系統的複雜性等因素也阻礙了市場的成長。

機會：人工智慧 (AI) 整合

人工智慧（AI）和機器學習（ML）在結構生物學和分子建模技術過程中的整合提高了資料分析的速度和準確性。人工智慧演算法可以分析生物資料來識別潛在的藥物研發標靶，為開發更有效率的藥物研發管道、提高治療效果並最大限度地減少副作用提供機會。我們提供此次整合將進一步提高該領域藥物研發發現和開發的效率、準確性和整體成功率。

威脅：初期成本高

結構生物學和分子建模技術通常需要昂貴的設備、軟體和熟練人員。它在很大程度上依賴尖端技術和專業設備。建立和維護最先進的實驗室和專業設施也需要大量的資本投資。此外，與分析實驗資料相關的成本，例如軟體許可證和解釋技術人員，也會增加整體初期成本並阻礙市場需求。

COVID-19 的影響

生命科學領域的許多研究工作都針對與新冠病毒相關的研究，包括疫苗開發、藥物再利用以及病毒結構和功能的闡明。這種資源的重新分配也影響了與新冠病毒無關的研究領域，例如結構生物學和分子建模。疫情期間的經濟不確定性和優先事項的轉變給研究計劃的資金籌措帶來了挑戰。此外，尋找新冠病毒治療方法的迫切需求增加了人們對抗病毒藥物發現的興趣和投資，間接使結構生物學和分子建模領域受益。

電子顯微鏡領域預計將在預測期內成為最大的領域

電子顯微鏡領域預計將出現良好的成長。電子顯微鏡技術提供高解析度，使研究人員能夠在分子甚至原子層面上可視化結構。電子顯微鏡是結構生物學和分子建模的強大工具，可提供對於理解生物過程和疾病機制至關重要的詳細結構資訊，並促進藥物研發工作。電磁技術的不斷進步正在增加其在該領域的重要性。

藥物研發領域預計在預測期內複合年成長率最高

預計藥物研發領域在預測期內將出現最高的複合年成長率。結構生物學和分子建模技術透過提供對疾病分子機制的寶貴見解並促進新療法的設計，在藥物研發中發揮重要作用。這些技術可以幫助簡化藥物研發流程，使其更有效率且更具成本效益。

比最大的地區

由於投資的增加和研發的進步，預計亞太地區在預測期內將佔據最大的市場佔有率。亞太地區的製藥和生物技術產業可能會對結構生物學和分子建模工具的需求做出重大貢獻。此外，政府對科學研究和生物技術的措施和資助也可以對市場產生積極影響。

複合年成長率最高的地區

由於不斷的進步、協作研究和夥伴關係，預計歐洲在預測期內將表現出最高的複合年成長率。政府資助、私人投資和津貼在促進該地區結構生物學和分子建模技術研究方面發揮著重要作用。歐洲市場的主要企業包括 Dassault Systemes、Agile Molecule 和 Acellera Limited。此外，資金籌措可用性和對個人化醫療日益成長的興趣可能會影響歐洲市場的成長。

免費客製化服務

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭關係

第5章全球結構生物學與分子建模技術市場：按產品

  • 試劑和套件
    • 蛋白質精製試劑
    • DNA和RNA萃取套件
    • 蛋白質結晶試劑
  • 裝置
    • X光結晶分析儀
    • 核磁共振 (NMR) 波譜儀
    • 質譜儀
  • 消耗品
    • 移液管和吸頭
    • 微孔板
    • 低溫儲存
  • 其他產品

第6章全球結構生物學與分子建模技術市場：依工具分類

  • 軟體即服務 (SaaS) 與獨立建模
    • 分子動力學
    • 同源建模
    • 螺紋切削
    • 從頭算
    • 混合
  • 視覺化和分析
  • 資料庫
  • 其他工具

第7章全球結構生物學與分子建模技術市場：依技術分類

  • 電子顯微鏡
  • 核磁共振 (NMR) 光譜
  • 計算建模
  • 其他技術

第8章全球結構生物學與分子建模技術市場：依應用分類

  • 藥物開發
  • 藥物研發
  • 其他用途

第9章全球結構生物學與分子建模技術市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Acellera Limited
  • Thermo Fisher Scientific Inc
  • Illumina Inc.
  • Horiba
  • Chemical Computing Group ULC
  • Bruker Daltonics
  • Agilent Technologies Inc.
  • Charles River Laboratories
  • Dassault Systemes
  • Biomax Informatics AG
  • Agile Molecule
  • Bioinformatic LLC
Product Code: SMRC24618

According to Stratistics MRC, the Global Structural Biology & Molecular Modeling Market is accounted for $4.91 billion in 2023 and is expected to reach $15.85 billion by 2030 growing at a CAGR of 18.2% during the forecast period. Structural Biology and Molecular Modeling are two closely related fields that play a crucial role in understanding the structure and function of biological macromolecules at the molecular level. They are versatile tools with applications ranging from basic research to practical applications in medicine, agriculture, and industry. They provide a molecular-level understanding of biological processes, facilitating advancements in various scientific and technological fields.

According to the MDPI Journal research article published in September 2021, the prevalence of Peripheral Arterial Disease (PAD) is estimated to be 3-12%, affecting nearly 27 million people in America and Europe.

Market Dynamics:

Driver:

Rising incidence of chronic diseases

Chronic diseases often involve complex molecular pathways. Structural biology helps identify and validate potential drug targets by providing detailed information. Structural biology and molecular modeling contribute to the identification of potential drug targets and the design of specific therapeutics. The increasing prevalence of chronic diseases, such as cancer and neurodegenerative disorders, has fuelled the demand for targeted and personalized therapies.

Restraint:

Limited understanding of biological systems

Despite advancements, understanding of complex biological systems is still evolving. A limited understanding of the three-dimensional structures of target proteins can impede the identification and design of effective drug candidates. This can result in a slower and less efficient drug development process. Additionally, factors such as inaccuracy in predicting protein-ligand interactions and complexities of biological systems hampers the market growth.

Opportunity:

Integration of artificial intelligence (AI)

The integration of artificial intelligence (AI) and machine learning (ML) in structural biology and molecular modeling processes enhances the speed and accuracy of data analysis. AI algorithms can analyze biological data to identify potential drug targets. It presents opportunities for the development of more efficient drug discovery pipelines, improving treatment efficacy and minimizing side effects. This integration further enhances the efficiency, accuracy, and overall success rate of drug discovery and development efforts in this field.

Threat:

High initial costs

Structural biology and molecular modeling techniques often involve expensive equipment, software, and skilled personnel. They heavily rely on cutting-edge technologies and specialized equipment. Also, establishing & maintaining state-of-the-art laboratories and specialized facilities requires significant capital investment. Additionally, the costs associated with analyzing experimental data, including software licenses and skilled personnel for interpretation contribute to the overall initial expenses thereby hampering the market demand.

COVID-19 Impact

Many research efforts in the life sciences were redirected toward covid related studies, including vaccine development, drug repurposing, and understanding the virus's structure and function. This redirection of resources has impacted non-covid-related research areas, including structural biology and molecular modeling. Economic uncertainties and shifting priorities during the pandemic have led to funding challenges for research projects. Further, the urgency of finding treatments for covid has spurred increased interest and investment in antiviral drug discovery, which indirectly benefitted the structural biology and molecular modeling sector.

The electron microscopy segment is expected to be the largest during the forecast period

The electron microscopy segment is estimated to have a lucrative growth. Electron microscopy technique offers high resolution and allows researchers to visualize structures at the molecular and even atomic levels. It is a powerful tool in structural biology and molecular modeling, providing detailed structural information that is crucial for understanding biological processes, disease mechanisms, and facilitating drug discovery efforts. The continuous advancements in EM technology further contribute to its significance in the field.

The drug discovery segment is expected to have the highest CAGR during the forecast period

The drug discovery segment is anticipated to witness the highest CAGR growth during the forecast period. Structural biology and molecular modeling play crucial roles in drug discovery by providing valuable insights into the molecular mechanisms of diseases and facilitating the design of novel therapeutic agents. These techniques help streamline the drug discovery pipeline, making it more efficient and cost-effective.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing investments and advances in research and development. The pharmaceutical and biotechnology industries in the Asia Pacific region are likely to contribute significantly to the demand for structural biology and molecular modeling tools. Further, government initiatives and funding for scientific research and biotechnology can positively influence the market.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to the continuous advancements, collaborations and partnerships. Government funding, private investments and grants play a significant role in advancing research in structural biology and molecular modeling in the region. Some prominent players in the European market include Dassault Systemes, Agile Molecule and Acellera Limited. Further, funding availability and growing emphasis on personalized medicine can impact the growth of the market in europe.

Key players in the market:

Some of the key players profiled in the Structural Biology & Molecular Modeling Market include Acellera Limited, Thermo Fisher Scientific Inc, Illumina Inc., Horiba, Chemical Computing Group ULC, Bruker Daltonics, Agilent Technologies Inc., Charles River Laboratories, Dassault Systemes, Biomax Informatics AG, Agile Molecule and Bioinformatic LLC.

Key Developments:

In November 2023, The Accelra Company released a new version of ACEMD, Accela's molecular dynamics simulation software. ACEMD is a highly optimized molecular dynamics (MD) engine that runs on NVIDIA GPUs. It's free for non-profit research, but commercial licenses are available for other uses.

In September 2023, Thermo Scientific launched the new Hydra Bio Plasma-Focused Ion Beam (Plasma-FIB) for cell biologists seeking simplified workflows while undertaking volume electron microscopy for cryo or resin-embedded samples. The Hydra Bio Plasma-FIB is a versatile, multi-application instrument that supports volume electron microscopy and sample preparation for the cryo-electron tomography workflow.

Products Covered:

  • Reagents & Kits
  • Instruments
  • Consumables
  • Other Products

Tools Covered:

  • Software as a Service (SaaS) & Standalone Modeling
  • Visualization & Analysis
  • Databases
  • Other Tools

Technologies Covered:

  • Electron Microscopy
  • Nuclear Magnetic Resonance (NMR) Spectroscopy
  • Computational Modeling
  • Other Technologies

Applications Covered:

  • Drug Development
  • Drug Discovery
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Structural Biology & Molecular Modeling Market, By Product

  • 5.1 Introduction
  • 5.2 Reagents & Kits
    • 5.2.1 Protein Purification Reagents
    • 5.2.2 DNA & RNA Extraction Kits
    • 5.2.3 Protein Crystallization Reagents
  • 5.3 Instruments
    • 5.3.1 X-ray Crystallography Instruments
    • 5.3.2 Nuclear Magnetic Resonance (NMR) Spectrometers
    • 5.3.3 Mass Spectrometers
  • 5.4 Consumables
    • 5.4.1 Pipettes & Tips
    • 5.4.2 Microplates
    • 5.4.3 Cryogenic Storage
  • 5.5 Other Products

6 Global Structural Biology & Molecular Modeling Market, By Tools

  • 6.1 Introduction
  • 6.2 Software as a Service (SaaS) & Standalone Modeling
    • 6.2.1 Molecular Dynamics
    • 6.2.2 Homology Modeling
    • 6.2.3 Threading
    • 6.2.4 Ab Initio
    • 6.2.5 Hybrid
  • 6.3 Visualization & Analysis
  • 6.4 Databases
  • 6.5 Other Tools

7 Global Structural Biology & Molecular Modeling Market, By Technology

  • 7.1 Introduction
  • 7.2 Electron Microscopy
  • 7.3 Nuclear Magnetic Resonance (NMR) Spectroscopy
  • 7.4 Computational Modeling
  • 7.5 Other Technologies

8 Global Structural Biology & Molecular Modeling Market, By Application

  • 8.1 Introduction
  • 8.2 Drug Development
  • 8.3 Drug Discovery
  • 8.4 Other Applications

9 Global Structural Biology & Molecular Modeling Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Acellera Limited
  • 11.2 Thermo Fisher Scientific Inc
  • 11.3 Illumina Inc.
  • 11.4 Horiba
  • 11.5 Chemical Computing Group ULC
  • 11.6 Bruker Daltonics
  • 11.7 Agilent Technologies Inc.
  • 11.8 Charles River Laboratories
  • 11.9 Dassault Systemes
  • 11.10 Biomax Informatics AG
  • 11.11 Agile Molecule
  • 11.12 Bioinformatic LLC

List of Tables

  • Table 1 Global Structural Biology & Molecular Modeling Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Structural Biology & Molecular Modeling Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Structural Biology & Molecular Modeling Market Outlook, By Reagents & Kits (2021-2030) ($MN)
  • Table 4 Global Structural Biology & Molecular Modeling Market Outlook, By Protein Purification Reagents (2021-2030) ($MN)
  • Table 5 Global Structural Biology & Molecular Modeling Market Outlook, By DNA & RNA Extraction Kits (2021-2030) ($MN)
  • Table 6 Global Structural Biology & Molecular Modeling Market Outlook, By Protein Crystallization Reagents (2021-2030) ($MN)
  • Table 7 Global Structural Biology & Molecular Modeling Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 8 Global Structural Biology & Molecular Modeling Market Outlook, By X-ray Crystallography Instruments (2021-2030) ($MN)
  • Table 9 Global Structural Biology & Molecular Modeling Market Outlook, By Nuclear Magnetic Resonance (NMR) Spectrometers (2021-2030) ($MN)
  • Table 10 Global Structural Biology & Molecular Modeling Market Outlook, By Mass Spectrometers (2021-2030) ($MN)
  • Table 11 Global Structural Biology & Molecular Modeling Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 12 Global Structural Biology & Molecular Modeling Market Outlook, By Pipettes & Tips (2021-2030) ($MN)
  • Table 13 Global Structural Biology & Molecular Modeling Market Outlook, By Microplates (2021-2030) ($MN)
  • Table 14 Global Structural Biology & Molecular Modeling Market Outlook, By Cryogenic Storage (2021-2030) ($MN)
  • Table 15 Global Structural Biology & Molecular Modeling Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 16 Global Structural Biology & Molecular Modeling Market Outlook, By Tools (2021-2030) ($MN)
  • Table 17 Global Structural Biology & Molecular Modeling Market Outlook, By Software as a Service (SaaS) & Standalone Modeling (2021-2030) ($MN)
  • Table 18 Global Structural Biology & Molecular Modeling Market Outlook, By Molecular Dynamics (2021-2030) ($MN)
  • Table 19 Global Structural Biology & Molecular Modeling Market Outlook, By Homology Modeling (2021-2030) ($MN)
  • Table 20 Global Structural Biology & Molecular Modeling Market Outlook, By Threading (2021-2030) ($MN)
  • Table 21 Global Structural Biology & Molecular Modeling Market Outlook, By Ab Initio (2021-2030) ($MN)
  • Table 22 Global Structural Biology & Molecular Modeling Market Outlook, By Hybrid (2021-2030) ($MN)
  • Table 23 Global Structural Biology & Molecular Modeling Market Outlook, By Visualization & Analysis (2021-2030) ($MN)
  • Table 24 Global Structural Biology & Molecular Modeling Market Outlook, By Databases (2021-2030) ($MN)
  • Table 25 Global Structural Biology & Molecular Modeling Market Outlook, By Other Tools (2021-2030) ($MN)
  • Table 26 Global Structural Biology & Molecular Modeling Market Outlook, By Technology (2021-2030) ($MN)
  • Table 27 Global Structural Biology & Molecular Modeling Market Outlook, By Electron Microscopy (2021-2030) ($MN)
  • Table 28 Global Structural Biology & Molecular Modeling Market Outlook, By Nuclear Magnetic Resonance (NMR) Spectroscopy (2021-2030) ($MN)
  • Table 29 Global Structural Biology & Molecular Modeling Market Outlook, By Computational Modeling (2021-2030) ($MN)
  • Table 30 Global Structural Biology & Molecular Modeling Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 31 Global Structural Biology & Molecular Modeling Market Outlook, By Application (2021-2030) ($MN)
  • Table 32 Global Structural Biology & Molecular Modeling Market Outlook, By Drug Development (2021-2030) ($MN)
  • Table 33 Global Structural Biology & Molecular Modeling Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 34 Global Structural Biology & Molecular Modeling Market Outlook, By Other Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.